Year |
Citation |
Score |
2013 |
Schmitt TM, Aggen DH, Stromnes IM, Dossett ML, Richman SA, Kranz DM, Greenberg PD. Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection. Blood. 122: 348-56. PMID 23673862 DOI: 10.1182/Blood-2013-01-478164 |
0.756 |
|
2009 |
Dossett ML, Teague RM, Schmitt TM, Tan X, Cooper LJ, Pinzon C, Greenberg PD. Adoptive immunotherapy of disseminated leukemia with TCR-transduced, CD8+ T cells expressing a known endogenous TCR. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 742-9. PMID 19209146 DOI: 10.1038/Mt.2008.300 |
0.708 |
|
2009 |
Richman SA, Aggen DH, Dossett ML, Donermeyer DL, Allen PM, Greenberg PD, Kranz DM. Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments. Molecular Immunology. 46: 902-16. PMID 18962897 DOI: 10.1016/J.Molimm.2008.09.021 |
0.537 |
|
2008 |
Rice J, Dossett ML, Ohlén C, Buchan SL, Kendall TJ, Dunn SN, Stevenson FK, Greenberg PD. DNA fusion gene vaccination mobilizes effective anti-leukemic cytotoxic T lymphocytes from a tolerized repertoire. European Journal of Immunology. 38: 2118-30. PMID 18624299 DOI: 10.1002/Eji.200838213 |
0.674 |
|
2008 |
Teague RM, Greenberg PD, Fowler C, Huang MZ, Tan X, Morimoto J, Dossett ML, Huseby ES, Ohlén C. Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor. Immunity. 28: 662-74. PMID 18424189 DOI: 10.1016/J.Immuni.2008.03.012 |
0.729 |
|
2007 |
Kuball J, Dossett ML, Wolfl M, Ho WY, Voss RH, Fowler C, Greenberg PD. Facilitating matched pairing and expression of TCR chains introduced into human T cells. Blood. 109: 2331-8. PMID 17082316 DOI: 10.1182/Blood-2006-05-023069 |
0.713 |
|
2006 |
Richman SA, Healan SJ, Weber KS, Donermeyer DL, Dossett ML, Greenberg PD, Allen PM, Kranz DM. Development of a novel strategy for engineering high-affinity proteins by yeast display. Protein Engineering, Design & Selection : Peds. 19: 255-64. PMID 16549400 DOI: 10.1093/Protein/Gzl008 |
0.579 |
|
2006 |
Teague RM, Sather BD, Sacks JA, Huang MZ, Dossett ML, Morimoto J, Tan X, Sutton SE, Cooke MP, Ohlén C, Greenberg PD. Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors. Nature Medicine. 12: 335-41. PMID 16474399 DOI: 10.1038/Nm1359 |
0.7 |
|
2004 |
Shur A, Hsing L, Yang Y, Dossett M, Ohlen C, Riddell S, Greenberg P. 396 Cd8+ T Cells As Immunogenic Vaccine Vehicles. Journal of Investigative Medicine. 52. DOI: 10.1136/Jim-52-Suppl1-396 |
0.607 |
|
2004 |
Shur A, Hsing L, Yang Y, Dossett M, Ohlen C, Riddell S, Greenberg P. CD8+ T CELLS AS IMMUNOGENIC VACCINE VEHICLES. Journal of Investigative Medicine. 52: S91. DOI: 10.1097/00042871-200401001-00074 |
0.607 |
|
2003 |
Ho WY, Blattman JN, Dossett ML, Yee C, Greenberg PD. Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction. Cancer Cell. 3: 431-7. PMID 12781360 DOI: 10.1016/S1535-6108(03)00113-2 |
0.727 |
|
Show low-probability matches. |